Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Atara Biotherapeutics, Inc (ATRA)

Biological Products, (no Disgnostic Substances)

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

2380 CONEJO SPECTRUM ST, SUITE 200
THOUSAND OAKS, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/16/2014

Market Cap

32,685,083

Shares Outstanding

101,920,000

Weighted SO

101,922,250

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

FATE --.--%

SANA --.--%

CRBU --.--%

RCUS --.--%

HRTX --.--%

ALLO --.--%

BTAI --.--%

KPTI --.--%

XFOR --.--%

Beta

0.5160

Last Div

0.0000

Range

4.975-49.0

Chg

-0.1800

Avg Vol

81406

Mkt Cap

32685083

Exch

NASDAQ

Country

US

Phone

650 278 8930

DCF Diff

7.5636

DCF

-0.9835

Div Yield

0.0000

P/S

0.5239

EV Multiple

-0.5658

P/FV

-0.3685

Div Yield %

0.0000

P/E

-0.2256

PEG

-0.0669

Payout

0.0000

Current Ratio

0.4209

Quick Ratio

0.2945

Cash Ratio

0.2122

DSO

14.7552

DIO

552.4651

Op Cycle

567.2202

DPO

154.7869

CCC

412.4334

Gross Margin

0.8014

Op Margin

-2.6810

Pretax Margin

-2.9018

Net Margin

-2.9020

Eff Tax Rate

-0.0001

ROA

-1.5437

ROE

2.0159

ROCE

5.3984

NI/EBT

1.0001

EBT/EBIT

1.0823

EBIT/Rev

-2.6810

Debt Ratio

0.4360

D/E

-0.4612

LT Debt/Cap

-0.4898

Total Debt/Cap

-0.8559

Int Coverage

-67.9366

CF/Debt

-2.7774

Equity Multi

-1.0579

Rec Turnover

24.7371

Pay Turnover

2.3581

Inv Turnover

0.6607

FA Turnover

1.2170

Asset Turnover

0.5319

OCF/Share

-23.1172

FCF/Share

-23.1955

Cash/Share

5.7688

OCF/Sales

-2.2763

FCF/OCF

1.0034

CF Coverage

-2.7774

ST Coverage

-9.6717

CapEx Coverage

-295.2370

Div&CapEx Cov

-295.2370

P/BV

-0.3685

P/B

-0.3685

P/S

0.5239

P/E

-0.2256

P/FCF

-0.2294

P/OCF

-0.2877

P/CF

-0.2877

PEG

-0.0669

P/S

0.5239

EV Multiple

-0.5658

P/FV

-0.3685

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 30, 22:39 Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws GlobeNewswire Inc. Nov 20, 21:47 FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Cell Therapy Facility Seeking Alpha Jan 05, 01:26 Atlanta Braves: This Yankees Fan Is A Buyer Seeking Alpha Jan 05, 01:26 Atlanta Braves: This Yankees Fan Is A Buyer Zacks Investment Research Nov 24, 12:29 Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why PennyStocks Nov 22, 15:14 Penny Stocks To Buy Under $1? 3 For Your Holiday Watch List PennyStocks Nov 17, 13:32 11 Top Penny Stocks To Buy Now According To Insiders PennyStocks Nov 17, 13:32 11 Top Penny Stocks To Buy Now According To Insiders PennyStocks Nov 15, 12:52 5 Penny Stocks To Buy Now According To Insiders PennyStocks Nov 15, 12:52 5 Penny Stocks To Buy Now According To Insiders Benzinga Nov 10, 11:00 Where Atara Biotherapeutics Stands With Analysts

Revenue Product Segmentation